Solving the mysteries of bioscience
Foundational Science Fuels Breakthroughs
Inspiring Next-Generation Scientists
Dr. Starczynowski is investigating the role and potential benefit of therapeutic targeting of a protein called UBE2N in acute myeloid leukemia (AML).
Daniel T. Starczynowski, Ph.D leads a laboratory at Cincinnati Children’s Hospital focused on the intersection of inflammation, innate immune signaling, and hematologic malignancies, with an emphasis on myelodysplastic syndromes and acute myeloid leukemia. Dr. Starczynowski is currently the Katherine Stewart Waters Endowed Chair in Hematologic Malignancies, professor in Pediatrics, and co-leader of the Hematologic Malignancies Program at Cincinnati Children’s Hospital.